Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

OCULOCUL
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in OCULAR THERAPEUTIX INC

GOLDMAN SACHS GROUP INC holds 1.8M shares of OCUL (OCULAR THERAPEUTIX INC), worth $17.3M as of 2026-Q2. The position was increased (+58.7% shares). OCUL represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$17.3M

Current Shares

1.8M

Total Value Change

+$11.6M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+58.7%
$17.3M0.0%$9.82
40
2026-Q1
Decreased
1.1M
-28.3%
$9.4M0.0%$10.76
0
2025-Q4
Increased
1.5M
+94.4%
$18.8M0.0%$12.20
45
2025-Q3
Increased
795,968
+31.5%
$9.3M0.0%$12.53
35
2025-Q2
Increased
605,165
+4.0%
$5.6M0.0%$9.22
28
2025-Q1
Decreased
582,009
-13.5%
$4.3M0.0%$7.58
0
2024-Q4
New
672,622
-
$5.7M0.0%$8.35
37

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used